The role of the sympathetic nervous system in obesity-related hypertension

被引:112
作者
da Silva, Alexandre A. [1 ]
do Carmo, Jussara [1 ]
Dubinion, John [1 ]
Hall, John E. [1 ]
机构
[1] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA
关键词
ARTERIAL-PRESSURE; BLOOD-PRESSURE; FOOD-INTAKE; ANGIOTENSIN HYPERTENSION; MELANOCORTIN SYSTEM; METABOLIC SYNDROME; SODIUM RETENTION; CONTROLLED-TRIAL; RENAL-DISEASE; NITRIC-OXIDE;
D O I
10.1007/s11906-009-0036-3
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Obesity is recognized as a major health problem throughout the world. Excess weight is a major cause of increased blood pressure in most patients with essential hypertension and greatly increases the risk for diabetes, cardiovascular diseases, and end-stage renal disease. Although the mechanisms by which obesity raises blood pressure are not completely understood, increased renal sodium reabsorption, impaired pressure natriuresis, and volume expansion appear to play important roles. Several potential mechanisms have been suggested to contribute to altered kidney function and hypertension in obesity, including activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system, as well as physical compression of the kidneys, especially when visceral obesity is present. Activation of the sympathetic nervous system in obesity may be due, in part, to hyperleptinemia and other factors secreted by adipocytes and the gastrointestinal tract, activation of the central nervous system melanocortin pathway, and baroreceptor dysfunction.
引用
收藏
页码:206 / 211
页数:6
相关论文
共 50 条
[1]  
Alexander J, 1979, US DHEW PUBLICATION, V70-1631, P61
[2]   Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension? [J].
Biaggioni, Italo .
HYPERTENSION, 2008, 51 (02) :168-171
[3]   Chronic cardiovascular and renal actions of leptin - Role of adrenergic activity [J].
Carlyle, M ;
Jones, OB ;
Kuo, JJ ;
Hall, JE .
HYPERTENSION, 2002, 39 (02) :496-501
[4]   CHRONIC ANGIOTENSIN-II INFUSION DECREASES RENAL NOREPINEPHRINE OVERFLOW IN CONSCIOUS DOGS [J].
CARROLL, RG ;
LOHMEIER, TE ;
BROWN, AJ .
HYPERTENSION, 1984, 6 (05) :675-681
[5]   Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome [J].
Correia, Marcelo L. G. ;
Rahmouni, Kamal .
DIABETES OBESITY & METABOLISM, 2006, 8 (06) :603-610
[6]   Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin [J].
da Silva, AA ;
Kuo, JJ ;
Hall, JE .
HYPERTENSION, 2004, 43 (06) :1312-1317
[7]   Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats [J].
da Silva, Alexandre A. ;
do Carmo, Jussara M. ;
Kanyicska, Bela ;
Dubinion, John ;
Brandon, Elizabeth ;
Hall, John E. .
HYPERTENSION, 2008, 51 (04) :884-890
[8]   Sympathetic nervous system behavior in human obesity [J].
Davy, Kevin P. ;
Orr, Jeb S. .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2009, 33 (02) :116-124
[9]   Obesity and hypertension: two epidemics or one? [J].
Davy, KP ;
Hall, JE .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2004, 286 (05) :R803-R813
[10]   Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration [J].
de Paula, RB ;
da Silva, AA ;
Hall, JE .
HYPERTENSION, 2004, 43 (01) :41-47